Efficacy of Some Medicinal Plants Used as Antidiabetic Plants in Jordan: A Review
Article Sidebar
Main Article Content
Abstract
Medicinal plants play a vital role in complementary and alternative treatments for non-
communicable diseases, including diabetes mellitus. In Jordan, extensive research by
phytochemists and botanists has documented the use of herbal medicine, particularly in rural areas
where it remains a primary form of treatment. Limited access to safe, effective, and affordable
pharmaceutical options often drives the reliance on herbal remedies in underdeveloped regions.
Similarly, in developed nations, concerns over side effects of synthetic pharmaceuticals have
increased the interest in natural treatment option for chronic illnesses. Ethnopharmacological
studies in Jordan have assessed the effectiveness of various plants in managing specific conditions,
particularly diabetes. Diabetes mellitus, known for its complications leading to morbidity and
mortality, has prompted many patients in Jordan to employ medicinal plants for the treatment of
this disease. Diabetic patients especially those in rural communities rely on the use of certain herbs
with hypoglycemic properties for the management of their condition. as supported by local
herbalists and researchers. Jordan is faced with an alarming rise in prevalence of diabetes,
necessitating proactive healthcare strategies that is focused on management and prevention.
Addressing this challenge requires the integration of herbal medicine into conventional healthcare
to mitigate the burden of diabetes mellitus.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
1. Arumugam G, Manjula P, Paari N. A review: Anti Diabetic Medicinal Plants Used for Diabetes Mellitus. J Acute Dis. 2013;
2(3):196-200.
2. Malviya N, Jain S, Malviya S. Antidiabetic Potential of Medicinal Plants. Acta Pol Pharm. 2010; 67(2):113-118.
3. Al-Azzam N, Al-Azzam S, Elsalem L, Karasneh R. Hypertension Prevalence and Associated Factors Among Patients With Diabetes: A Retrospective Cross-Sectional Study From Jordan. Ann Med Surg. 2021; 61:126-131.
4. Association AD. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2006; 29(1):S43-S48.
5. Shaw JE, Zimmet PZ, McCarty D, De Courten M. Type 2 Diabetes Worldwide According to the New Classification and Criteria. Diabetes Care. 2000; 23(2):B5-10.
6. Williams R, Karuranga S, Malanda B, Saeedi P, Basit A, Besançon S, Bommer C, Esteghamati A, Ogurtsova K, Zhang P,
Colagiuri S. Global and regional estimates and projections of diabetes-related health expenditure: Results from the
International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract. 2020; 16(2):108072.
7. Ajlouni K, Batieha A, Jaddou H, Khader Y, Abdo N, El‐Khateeb M, Hyassat D, Al-Louzi D. Time Trends in Diabetes Mellitus in
Jordan Between 1994 and 2017. Diabetic Medicine. 2019; 36(9):1176-1182.
8. World Health Organization (WHO). Global Report on Diabetes: World Health Organization; 2016.
9. Al-Sahouri A, Merrell J, Snelgrove S. Barriers To Good Glycemic Control Levels And Adherence To Diabetes Management Plan In Adults With Type-2 Diabetes In Jordan: A Literature Review. Patient Pref Adher. 2019; 1(3):675-693.
10. Obeidat AA, Ahmad MN, Haddad FH, Azzeh FS. Alarming High Prevalence of Metabolic Syndrome Among Jordanian Adults.
Pak J Med Sci. 2015; 31(6):1377-1382.
11. Awad SF, Huangfu P, Dargham SR, Ajlouni K, Batieha A, Khader YS, Julia A, Critchley JA, Abu-Raddad LJ. Characterizing the Type 2 Diabetes Mellitus Epidemic In Jordan Up to 2050. Sci Rep. 2020; 10(1):1-10.
12. Saad AM, Hiyasat D, Jaddou H, Obeidat N. The Prevalence of High Risk Obstructive Sleep Apnoea Among Patients With Type 2 Diabetes in Jordan. Diabetes Res Clin Pract. 2019; 15(2):16-22.
13. Al-Till MI, Al-Bdour MD, Ajlouni KM. Prevalence Of Blindness and Visual Impairment Among Jordanian Diabetics. Eur J
Ophthalmol. 2005; 15(1):62-68.
14. Khawaja N, Abu-Shennar J, Saleh M, Dahbour SS, Khader YS, Ajlouni KM. The Prevalence and Risk Factors of Peripheral
Neuropathy Among Patients With Type 2 Diabetes Mellitus; The Case Of Jordan. Diabetol Metab Syndr. 2018; 10(1):1-10.
15. Salehi B, Ata A, V. Anil Kumar N, Sharopov F, Ramirez- Alarcon K, Ruiz-Ortega A, Ayatollahi SA, Tsouh Fokou PV,
Kobarfard F, Zakaria ZA, Iriti M, Taheri Y, Martorell M, Sureda A, Setzer WN, Durazzo A, Lucarini M, Santini A, Capasso R,
Ostrander EA, Atta-ur-Rahman, Choudhary MI, Cho WC, Sharifi-Rad J. Antidiabetic Potential of Medicinal Plants and
Their Active Components. Biomolecules. 2019; 9(10):551.
16. DeFronzo RA. Pharmacologic Therapy For Type 2 Diabetes Mellitus. Ann Intern Med. 1999; 131(4):281-303.
17. Bawadi H, Abu-Jamous D, Tayyem RF. Evaluation of the Dietary Pattern Of Patients With Type 2 Diabetes In Northern
Jordan: An Inconvenient Truth! Int J Diabetes Dev Ctries. 2014; 34(3):134-138.
18. Garg A. High-monounsaturated-fat Diets for Patients With Diabetes Mellitus: A Meta-Analysis. Am J Clin Nutr. 1998;
67(3):577S-582S.
19. Chandalia M, Garg A, Lutjohann D, Von Bergmann K, Grundy SM, Brinkley LJ. Beneficial Effects of High Dietary Fiber Intake
in Patients With Type 2 Diabetes Mellitus. N Engl J Med. 2000; 342(19):1392-1398.
20. Gross LS, Li L, Ford ES, Liu S. Increased Consumption of Refined Carbohydrates and the Epidemic of Type 2 Diabetes in
the United States: An Ecologic Assessment. The American Journal Of Clinical Nutrition. 2004; 79(5):774-779.
21. Pereira EV, Costa JdA, Alfenas RdCG. Effect of Glycemic Index on Obesity Control. Arch Endocrinol Metab. 2015; 5(9):245-251.
22. Alkurd RA, Takruri HR, Muwalla MM, Arafat TA. Glycemic and Insulinemic Responses of Multi-Grain Types of Bread
Marketed in Jordan. Curr Res Nutr Food Sci J. 2020; 8(2):640-648.
23. Tayyem RF, Al Hazzaa HM, Abu-Mweis SS, Bawadi HA, Hammad SS, Musaiger AO. Dietary Habits and Physical Activity
Levels in Jordanian Adolescents Attending Private Versus Public Schools. East Mediterr Health J. 2014; 20(7):416-423.
24. Hiba B, Zaid A-H, Hala B, Omar E, Fwzieh H, Lana A. Cultural Eating Practices Among Jordanians. Food Nutr Sci. 2012; 3(6)
835-840.
25. Román G, Jackson R, Gadhia R, Román A, Reis J. Mediterranean diet: The Role Of Long-Chain Ω-3 Fatty Acids In Fish;
Polyphenols In Fruits, Vegetables, Cereals, Coffee, Tea, Cacao and Wine; Probiotics and Vitamins in Prevention of Stroke, Age-
Related Cognitive Decline, and Alzheimer Disease. Rev Neurol. 2019; 175(10:724-741.
26. Buescher MI and Gallaher DD. Wheat Color Class, Not Refining, Influences Colon Cancer Risk in Rats. Nutr Cancer. 2014; 66(5):849-856.
27. Haas P, Machado M, Anton A, Silva A, De Francisco A. Effectiveness of Whole Grain Consumption in the Prevention of Colorectal Cancer: Meta-Analysis of Cohort Studies. Int J Food Sci Nutr. 2009; 60(6):1-13.
28. Tayyem RF, Bawadi HA, Shehadah I, Agraib LM, Al-Awwad NJ, Heath DD, Bani-Hani KE. Consumption of Whole Grains,
Refined Cereals, and Legumes and Its Association With Colorectal Cancer Among Jordanians. Integr Cancer Ther. 2016;
15(3):318-325.
29. Ibrahim M, Davies MJ, Ahmad E, Annabi FA, Eckel RH, Ba- Essa EM, El Sayed NA, Hess Fischl A, Houeiss P, Iraqi H, Khochtali I, Khunti K, Masood SN, Mimouni-Zerguini S, Shera S, Tuomilehto J, Umpierrez GE. Recommendations for
Management of Diabetes During Ramadan: Update 2020, Applying the Principles of the ADA/EASD Consensus. BMJ Diabetes Res Care. 2020; 81:e001248.
30. Miller JC. Importance of Glycemic Index in Diabetes. Ame J Clin Nutr. 1994; 59(3):747S-752S.
31. Rahelić D, Jenkins A, Božikov V, Pavić E, Jurić K, Fairgrieve C, Romić D, Kokić S, Vuksan V. Glycemic Index in Diabetes. Coll
Antropol. 2011; 35(4):1363-1368.
32. Brand-Miller J, Hayne S, Petocz P, Colagiuri S. Low–glycemic Index Diets In The Management of Diabetes: A Meta-analysis of Randomized Controlled Trials. Diabetes Care. 2003; 26(8):2261-2267.
33. Kopelman PG. Obesity as a Medical Problem. Nature. 2000; 4046778:635-643.
34. El-Qudah JM. Food Consumption Patterns and Prevalence Of Obesity in an Adult Population In Amman, Jordan. Aust J Basic Appl Sci. 2008; 2(4):1165-1171.
35. Alberti KGMM and Zimmet PZ. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1:
Diagnosis and Classification of Diabetes Mellitus. Provisional Report of a WHO Consultation. Diabetic Med. 1998; 15(7):539-
553.
36. Ajlouni K, Khader Y, Batieha A, Jaddou H, El-Khateeb M. An Alarmingly High and Increasing Prevalence of Obesity In
Jordan. Epidemiol Health. 2020; 42:e2020040.
37. Boutayeb A, Lamlili ME, Boutayeb W, Maamri A, Ziyyat A, Ramdani N. The Rise of Diabetes Prevalence in the Arab Region.
Open J Epidemiol. 2012; 2(2):55-60.
38. Al-Shudifat A-E, Johannessen A, Azab M, Al-Shdaifat A, AbuMweis SS, Agraib LM, Tayyem RF. Risk Factors for Coronary Artery Disease in Patients Undergoing Elective Coronary Angiography in Jordan. BMC Cardiovas Disord. 2017; 17(1):1-5.
39. Sharara E, Akik C, Ghattas H, Makhlouf Obermeyer C. Physical Inactivity, Gender and Culture in Arab Countries: A Systematic Assessment of the Literature. BMC Public Health. 2018; 18(1):1- 19.
40. AL-Dalaen BD and Al-Wahsh ZH. Physical Activity CorrelatesAmong Jordanian Diabetes Patients. Malay J Med Health Sci.
2022; 18(1):105-113.
41. Irshaid F. Prevalence of Insulin-Treated Type 2 DiabetesMellitus in Northern Jordan: Life Style, Familial Inheritance and
Maternal Influence. Eur Sci J. 2014; 10(12): 123-131.
42. Ajlouni K, Khader YS, Batieha A, Ajlouni H, El-Khateeb M. AnIncrease in Prevalence of Diabetes Mellitus in Jordan Over 10
Years. J Diabetes Complic. 2008; 22(5):317-324.
43. Alberti G, Zimmet P, Shaw J, Grundy SM. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Brussels: Int
Diabetes Fed. 2006; 23(5):469-480.
44. Alhaik S, Anshasi HA, Alkhawaldeh Jf, Soh KL, Naji AM. An Assessment of Self-care Knowledge Among Patients with
Diabetes Mellitus. Diabetes & Metabolic Syndrome: Clin Res Rev. 2019; 13(1):390-394.
45. Khader Y, Batieha A, Jaddou H, El-Khateeb M, Ajlouni K. The Performance of Anthropometric Measures to Predict Diabetes
Mellitus and Hypertension Among Adults in Jordan. BMC Pub Health. 2019; 19(1):1-9.
46. Mwafi NR, Al-Rawashdeh IM, Al-Kubaisy WA-Q, Ezzat WR, Al-Qazaqi RA, Salameh MH. Prevalence and Factors Related to Fast Food Consumption Among Mutah University Students, Jordan. J Pak Med Assoc. 2021; 71(6):1608-1612.
47. Alkhalidy H, Orabi A, Alzboun T, Alnaser K, Al-Shami I, Al- Bayyari N. Health-Risk Behaviors and Dietary Patterns Among
Jordanian College Students: A Pilot Study. Front Nutr. 2021: 225.
48. Cassidy S, Chau JY, Catt M, Bauman A, Trenell MI. Cross-Sectional Study of Diet, Physical Activity, Television Viewing
and Sleep Duration in 233 110 Adults from the UK Biobank; The Behavioural Phenotype Of Cardiovascular Disease and Type 2
Diabetes. BMJ Open. 2016; 15:6(3):e010038.
49. Alqaraleh M, Kasabri V, Farha RA, Naffa RG, Yousef I, Aljaafreh A. Branched Amino Acids as Potential Biomarkers in
Metabolic Syndrome Patients and as Hypolipidemic Compounds. Eur Asian J BioSci. 2019; 13(2):2233-2241.
50. Pengpid S and Peltzer K. Skipping Breakfast and Its Association With Health Risk Behaviour and Mental Health Among
University Students in 28 Countries. Diabetes, Metabolic Syndrome and Obesity: Targ Ther. 2020; 13:2889.- 2899.
51. San Martini MC, de Assumpcao D, de Azevedo Barros MB, de Azevedo Barros Filho A, Mattei J. Weight Self-perception in
Adolescents: Evidence from a Population-based Study. Public Health Nutr. 2021; 24(7):1648-1656.
52. Jarab AS, Alefishat E, Mukattash TL, Albawab AQ, Abu-Farha RK, McElnay JC. Exploring variables associated with poor
health-related quality of life in patients with type 2 diabetes in Jordan. J Pharm Health Serv Res. 2019; 10(2):211-217.
53. Holmes-Truscott E, Blackberry I, O’Neal DN, Furler JS, Speight J. Willingness to Initiate Insulin Among Adults With Type 2
Diabetes in Australian Primary Care: Results from the Stepping Up Study. Diabetes Res Clin Pract. 2016; 11(4):126-135.
54. Al-Sahouri A, Merrell J, Snelgrove S. Attitudes, Knowledge, and Perceptions of Patients Regarding type-2 Diabetes in Jordan. J Diabetes Mellitus. 2019; 9(1):1-13.
55. Khattab M, Khader YS, Al-Khawaldeh A, Ajlouni K. Factors Associated with Poor Glycemic Control Among Patients With
Type 2 Diabetes. J Diabetes Complic. 2010; 24(2):84-89.
56. Darawad MW, Mosleh S, Khalil AA, Maharmeh M, Hamdan- Mansour AM, Samarkandi OA. Investigating Physical Exercise
Among Jordanians With Diabetes Mellitus. Health. 2016; 80(2):181-188.
57. Tremblay MS, Aubert S, Barnes JD, Saunders TJ, Carson V, Latimer-Cheung AE, et al. Sedentary Behavior Research
Network SBRN–Terminology Consensus Project Process and Outcome. Int J Behav Nutr Phys Act. 2017; 14(1):1-17.
58. Barghouti F, AbuRmaileh NN, Jallad DG, Abd-Qudah Y. Leisure Time Physical Activity in Jordan: Knowledge and
Sociodemographic Determinants. Int Med J. 2015; 22(4)283-287.
59. Kooti W, Moradi M, Ali-Akbari S, Sharafi-Ahvazi N, Asadi- Samani M, Ashtary-Larky D. Therapeutic and Pharmacological
Potential of Foeniculum Vulgare Mill: A Review. J Herb Med Pharmacol. 2015; 4(1):1-9.
60. Durazzo A and Lucarini M. A Current Shot and Re-thinking of Antioxidant Research Strategy. Braz J Anal Chem. 2018;
5(20):9-11.
61. Wazaify M, Afifi FU, El-Khateeb M, Ajlouni K. Complementary and Alternative Medicine Use Among Jordanian Patients With
Diabetes. Complement Ther Clin Pract. 2011; 17(2):71-75.
62. Afifi-Yazar FU, Kasabri V, Abu-Dahab R. Medicinal Plants from Jordan in the Treatment of Diabetes: Traditional Uses Vs.
In Vitro and In Vivo Evaluations–Part 2. Planta Med. 2011; 77(11):1210-1220.
63. Afifi FU and Kasabri V. Pharmacological and Phytochemical Appraisal of Selected Medicinal Plants from Jordan With
Claimed Antidiabetic Activities. Sci Pharm. 2013; 81(4):889-932.
64. Sofowora A, Ogunbodede E, Onayade A. The Role and Place of Medicinal Plants in the Strategies for Disease Prevention. Afr JTradit Complement Altern Med. 2013; 10(5):210-229.
65. Al-Sahouri A, Merrell J, Snelgrove S. Barriers to Good Glycemic Control Levels and Adherence to Diabetes Management Plan in Adults With Type-2 Diabetes in Jordan: A Literature Review. Patient Prefer Adher. 2019; 13:675-693.
66. Atlas D. IDF diabetes atlas. International Diabetes Federation 9th edition Retrieved from http://www idf org/about-diabetes/facts-figures. 2019.
67. Yousef I, Oran S, Bustanji Y, Al-Eisawi D, Abu-Irmaileh B. Cytotoxic Effect of Selected Wild Medicinal Plant Species from
Jordan on two Different Breast Cancer Cell Lines, MCF7 And T47D. Biol Med. 2018;10(4):443.
68. Abu-Zaiton A, Abu-Samak M, Oran S, Yousef I, Abu-Zaitoon Y, Algaramseh A. Hypoglycemic, Hypolipidimic and Protective
Effects of Arbutus Andrachne Extract in Streptozotocin Induced Diabetic Rats. Res J Biol Sci. 2019;14(3):56-60.
69. Yousef I, Oran S, Alqaraleh M, Bustanji Y. Evaluation of Cytotoxic, Antioxidant and Antibacterial Activities of Origanum
dayi, Salvia palaestina and Bongardia chrysogonum Plants Growing Wild in Jordan Trop J Nat Prod Res. 2021; 5(1):66-70
70. Al-Aboudi A and Afifi FU. Plants used for the treatment of diabetes in Jordan: A review of scientific evidence. Pharm Biol.
2011; 49(3):221-239.
71. Mukherjee PK, Maiti K, Mukherjee K, Houghton PJ. Leads from Indian Medicinal Plants With Hypoglycemic Potentials. J
Ethnopharmacol. 2006; 106(1):1-28.
72. Prabhakar PK and Doble M. A Target Based Therapeutic Approach Towards Diabetes Mellitus Using Medicinal Plants.
Curr Diabetes Rev. 2008; 4(4):291-308.
73. Ardestani A and Yazdanparast R. Antioxidant and Free Radical Scavenging Potential of Achillea santolina Extracts. Food Chem. 2007;104(1):21-29.
74. Hasani-Ranjbar S, Larijani B, Abdollahi M. A Systematic Review of Iranian Medicinal Plants Useful in Diabetes Mellitus.
Arch Med Sci. 2008; 4(3):285-292.
75. Abdel-Zaher AO, Salim SY, Assaf MH, Abdel-Hady RH. Antidiabetic Activity and Toxicity of Zizyphus spina-christi Leaves. J Ethnopharmacol. 2005; 101(1-3):129-138.
76. Nesseem D, Michel C, Sleem A, El-Alfy T. Formulation and Evaluation of Antihyperglycemic Leaf Extracts of Zizyphus
spina-christi L. Willd. Die Pharmazie-An Int J Pharm Sci. 2009; 64(2):104-109.
77. Idm’hand E, Msanda F, Cherifi K. Ethnopharmacological Review of Medicinal Plants Used to Manage Diabetes in
Morocco. Clin Phytosci. 2020; 6(1):1-32.
78. Al-Halaseh L. Some Herbal Medicine Traditionally Used in South Jordan. Al-Azhar J Pharm Sci. 2013; 47(1):63-82.
79. Berramdane T, Gourine N, Bombarda I, Yousfi M. New Chemotype of Essential Oil of Achillea santolina L. Collected
From Different Regions of Algeria. J Food Meas Charact. 2018; 12(3):1779-1786.
80. Boissier E. Diagnoses Plantarum orientalium novarum: B. Hermann; 1849.
81. De Roziere M. Mineralogical Description of the Valley of Qoceyr. In Description of Egypt, Natural History, Vol. 2. Paris:
Imperial Printing House. 181(3):83–98.
82. Sturtevant EL. The History of Garden Vegetables Continued. The American Naturalist. 1890; 24284:719-744.
83. Spencer M. LINNAEUS, Carl. Species plantarum 1753. Volumes 1 and 2, with an introduction by WT Stearn and appendix by JL Heller and WT Stearn, plus supplements by CE Jarvis. Edinburgh University Press The Tun-Holyrood Road, 12 2f Jackson's Entry 2016.
84. Öztürk M, Aydoğmuş-Öztürk F, Duru ME, Topçu G. Antioxidant Activity of Stem and Root Extracts of Rhubarb Rheum Ribes: An Edible Medicinal Plant. Food Chem. 2007; 103(2):623-630.
85. Saied AS, Gebauer J, Hammer K, Buerkert A. Ziziphus spina-christi L. Willd.: A Multipurpose Fruit Tree. Genet Resour Crop
Evol. 2008; 5(5):929-937.
86. Henkin Z, Rosenzweig T, Yaniv Z. Sarcopoterium spinosum. Medicinal and Aromatic Plants of the Middle-East. Springer,
2014. 151-161 p.
87. Joshi BC, Mukhija M, Kalia AN. Pharmacognostical Review of Urtica dioica L. Int J Green Pharm. 2014; 8(4):201-209.
88. Laribi B, Kouki K, M'Hamdi M, Bettaieb T. Coriander Coriandrum sativum L. and its Bioactive Constituents. Fitoter.
2015; 10(3):9-26.
89. Mnif S and Aifa S. Cumin Cuminum cyminum L. from Traditional Uses to Potential Biomedical Applications. Chem Biodivers. 2015; 12(5):733-742.
90. Kikowska M, Dworacka M, Kędziora I, Thiem B. Eryngium creticum–Ethnopharmacology, Phytochemistry and
Pharmacological Activity. A Review. Revista Brasileira de Farmacognosia. 2016; 2(6):392-399.
91. Umamaheswari M, Asokkumar K, Sivashanmugam A, Remyaraju A, Subhadradevi V, Ravi T. In Vitro Xanthine
Oxidase Inhibitory Activity of the Fractions of Erythrina Stricta Roxb. J Ethnopharmacol. 2009; 124(3):646-648.